Millendo Therapeutics, Inc. announced that Tracy Saxton of the Roche Venture Fund will join Millendo's Board of Directors and Carol Gallagher will represent New Enterprise Associates, shifting from her role as an independent board member.
Millendo Therapeutics
Equities
MLND
US60040X1037
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |